The stock of Innoviva Inc (NASDAQ:INVA) is a huge mover today! About 1.03M shares traded hands or 38.34% up from the average. Innoviva Inc (NASDAQ:INVA) has declined 27.35% since April 5, 2016 and is downtrending. It has underperformed by 29.31% the S&P500.
The move comes after 6 months positive chart setup for the $1.16B company. It was reported on Nov, 8 by Barchart.com. We have $15.99 PT which if reached, will make NASDAQ:INVA worth $614.80M more.
According to Zacks Investment Research, “Innoviva, Inc. is focused on the development, commercialization and financial management of bio-pharmaceuticals. The company’s portfolio of respiratory assets partnered with Glaxo Group Limited, including RELVAR(R)/BREO(R) ELLIPTA(R) and ANORO(R) ELLIPTA(R). Innoviva, Inc., formerly known as Theravance, Inc., is headquartered in South San Francisco, California.”
More recent Innoviva Inc (NASDAQ:INVA) news were published by: Marketwatch.com which released: “Innoviva Inc. NASDAQ: INVA” on May 21, 2011. Also Seekingalpha.com published the news titled: “Innoviva: On Track To Buy Back The Whole Company” on February 04, 2016. Seekingalpha.com‘s news article titled: “Innoviva: Finally Starting To Gain Some Trust” with publication date: July 29, 2016 was also an interesting one.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.